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To examine the relationship between baseline structural characteristics of the optic nerve
head (ONH) and retinal nerve fiber layer (RNFL) and functional disease progression in
patients with open-angle glaucoma (OAG) over 5 years.
Methods
112 OAG patients were prospectively examined at baseline and every 6 months over a
period of five years. Structural glaucomatous changes were examined with optical coher-
ence tomography (OCT) and Heidelberg retinal tomography-III (HRT-III), and functional dis-
ease progression with automated perimetry (Humphrey visual fields). Cox proportional
hazard models were used to assess the relationship between baseline structural measure-
ments and functional disease progression.
Results
From baseline over a 5-year period, statistically significant increases were found in OCT
disc (D) area (p<0.001), cup (C) area (p<0.001), C/D area ratio (p<0.001), C/D horizontal
ratio (p<0.001), C/D vertical ratio (p = 0.018), and a decrease in superior RNFL thickness (p
= 0.008). Statistically significant increases were found in HRT-III C volume (p = 0.021), C/D
area ratio (p = 0.046), mean C depth (p = 0.036), C shape (p = 0.008), and height variation
contour (p = 0.020). Functional disease progression was detected in 37 of the 112 patients
(26 of European descent and 11 of African descent; 33%). A statistically significant shorter
time to functional progression was seen in patients with larger baseline OCT D area (p =
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0.008), C area (p = 0.003), thicker temporal RNFL (p = 0.003), and in patients with a larger
HRT-III C area (p = 0.004), C/D area ratio (p = 0.004), linear C/D ratio (p = 0.007), C shape
(p = 0.032), or smaller rim area (p = 0.039), rim volume (p = 0.005), height variation contour
(p = 0.041), mean RNFL thickness (p<0.001), or RNFL cross-sectional area (p = 0.002).
Conclusion
Baseline ONH and RNFL structural characteristics were associated with a significantly
shorter time to functional glaucomatous progression and visual field loss through the five-
year period in OAG patients.
Introduction
Primary open-angle glaucoma (OAG) is a multifactorial optic neuropathy characterized by
progressive retinal ganglion cell death and a characteristic visual field (VF) loss [1]. Elevated
intraocular pressure (IOP) has been identified as a major risk factor for OAG, and current
treatments are limited to reducing and controlling IOP to arrest disease progression. Despite
advances in pharmacological and surgical interventions, it is well established that glaucoma
progression is still observed in some patients with IOP reduction. Additionally, a high percent-
age of individuals with ocular hypertension do not develop glaucoma [2–4]. These findings
suggest that glaucomatous progression is multifactorial and other underlying factors contrib-
ute to disease onset and progression.
Many studies have been performed in order to identify IOP-independent risk factors for
primary OAG. In particular, the presence of exfoliation, bilateral disease, advanced age, disc
hemorrhages, thinner central corneas, lower systolic perfusion pressure, lower systolic blood
pressure, and cardiovascular disease have been identified as predictors for glaucoma progres-
sion [5–7]. In addition, a history of migraine, female gender, increased vertical and horizontal
cup-disc ratios, and pattern standard deviation were also found to be predictors for the devel-
opment of glaucoma [5–8]. Many risk factors have been identified to help stratify at-risk
patients within the population; however, specificity of biomarkers and their relative weight of
contribution in the rate of progression is not currently well understood and severely limits
physician management and intervention targets.
The multifactorial nature of glaucoma has led to the investigation of structural measure-
ments as indicators of functional disease progression in glaucoma patients. Structural differ-
ences and changes to the ONH and RNFL have been shown to contribute to the onset and
progression of OAG. Many studies, including the Ocular Hypertension Treatment Study, have
found the vertical and horizontal cup-disc ratios to be strong structural predictors for the
onset of OAG [8, 9]. Because of these findings, others have investigated the utility of various
imaging modalities on determining structural differences between normal healthy eyes and
those suffering from glaucoma [10–12]. These studies have found that baseline structural mea-
surements, including RNFL thinning and cup shape, are associated with functional glaucoma-
tous progression [13–16]. However, the results from these studies are varied, and the exact
relationship between baseline structural characteristics of the ONH and RNFL and functional
disease progression has not been fully delineated.
Many of these previous studies are limited in the specific structural measurements they
investigate and vary in the statistical significance of their findings. Determining whether OAG
patients will experience visual field changes affecting their quality of life is key in optimizing
PLOS ONE Structure and function in open-angle glaucoma
PLOS ONE | https://doi.org/10.1371/journal.pone.0236819 August 20, 2020 2 / 11
Luseed, Oxymap, Phileas Pharma, and QuLent. All
relationships listed above are pursuant to Icahn
School of Medicine’s policy on outside activities.
Dr. Ingrida Januleviciene would like to disclose that
she receives honoraria from Santen, and she
receives remuneration from Santen and Thea for
serving as a consultant. The contribution of the
author Dr. Alice C. Verticchio Vercellin was
supported by Fondazione Roma and by the Italian
Ministry of Health. The specific roles of these
authors are articulated in the ‘author contributions’
section. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist. Dr. Alon Harris
would like to disclose that he received
remuneration from Adom and Luseed for serving
as a consultant, and he serves on the board of
Adom and Phileas Pharma. Dr. Harris also holds an
ownership interest in AdOM, Luseed, Oxymap,
Phileas Pharma, and QuLent. All relationships listed
above are pursuant to Icahn School of Medicine’s
policy on outside activities. Dr. Ingrida
Januleviciene would like to disclose that she
receives honoraria from Santen, and she receives
remuneration from Santen and Thea for serving as
a consultant. The contribution of the author Dr.
Alice C. Verticchio Vercellin was supported by
Fondazione Roma and by the Italian Ministry of
Health. There are no patents, products in
development or marketed products to declare. This
does not alter our adherence to PLOS ONE policies
on sharing data and materials.
their treatment and care. Consequently, the development of predictive tools and/or models for
glaucoma progression is a heavily-researched topic at this time [17, 18]. Currently, however,
there is a paucity of information and tools that help glaucoma specialists in determining treat-
ment. Here, we present data from a large, 5-year longitudinal study that aims to expand upon
previous research and to evaluate baseline structural measurements that may predict which
patients are at risk for functional glaucomatous progression after five years.
Materials and methods
A cohort of 112 patients with OAG were enrolled at baseline, and prospectively examined at
baseline and every 6 months over a period of five years at the Glaucoma and Diagnostic Center
at Indiana University School of Medicine, Indianapolis, Indiana. Ethics approval was obtained
by the Indiana University School of Medicine Institutional Review Board committee at the
Indiana University School of Medicine. All patients signed an informed consent prior to initia-
tion of this study, which adhered to the tenets of the Declaration of Helsinki. Our study was
observational, and all medical management was performed by the patient’s physician and
without regard to study participation. All participants were required to meet the following
inclusion criteria: age 30 years or older and best-corrected visual acuity of 20/60 or better in
the study eye. In addition, to be included, the clinical diagnosis of OAG had to be confirmed
in the study eye by a fellowship-trained glaucoma specialist based upon criteria representative
of glaucomatous optic disc or retinal nerve fiber layer (RNFL) structural abnormalities and/or
automated perimetry visual field changes consistent with glaucomatous damage.
Patients were excluded for the following reasons: evidence of pseudoexfoliation or pigment
dispersion, history of acute angle-closure glaucoma or a narrow occludable anterior chamber
angle, history of chronic or recurrent inflammatory eye diseases, history of intraocular trauma,
severe or progressive retinal disease, any abnormality preventing reliable applanation tonome-
try, cataract surgery within the past year, resting pulse < 50 beats per minute, or uncontrolled
cardiovascular, renal, or pulmonary disease. Participants were allowed to continue their pre-
ventative blood pressure (BP) and cholesterol lowering medications. The data were categorized
into groups of African Descent (AD) or European Descent (ED) based on self-reported race.
Reporting of races other than AD or ED were excluded from this analysis.
One qualified eye was randomly designated as the observational study eye in each subject.
All patients were questioned for their demographics, clinical history, ophthalmic history and
medications, and systemic diseases and medications. Each subject was evaluated for heart rate
(HR) and BP, which was assessed using an automated ambulatory blood pressure monitor
after five minutes of rest. A comprehensive ophthalmological examination was performed
including slit lamp evaluation, gonioscopy, central corneal thickness and axial length measure-
ments, IOP measurement using Goldmann applanation tonometry, and indirect dilated oph-
thalmoscopy with a 90 diopters lens.
To limit reproducibility bias with imaging, a single experienced operator with over ten
years of experience performed all measurements in the same order and at the same time of the
day for each patient. Visual function was assessed by the Humphrey Field Analyzer II (HFA
II), using the 24–2 Swedish Interactive Threshold Algorithm (SITA) standard (white III stimu-
lus) version 4.1 (Carl Zeiss Meditec Inc, Dublin, CA). VF progression was determined using
the Humphrey Glaucoma Progression Analysis (GPA) software [19]. Functional glaucoma
progression was defined as 2 consecutive visits with an Advanced Glaucoma Index Study
(AGIS) score increase�2 from baseline or a mean deviation (MD) decrease�2 from baseline.
RNFL thickness and optic nerve head (ONH) structures were assessed using both optical
coherence tomography (OCT) (Stratus software V.4.0, Zeiss Meditec, Dublin, California,
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USA) and Heidelberg retinal tomography-III (HRT-III) (Heidelberg Engineering, Heidelberg,
Germany) where HRT-III was utilized to supplement OCT evaluations for subtle RNFL and/
or ONH changes. Measurements were made along a circle concentric with the optic disc (Fast
RNFL Thickness acquisition protocol) to assess RNFL thickness. The RNFL thickness and
cup/disc vertical and horizontal ratios were calculated using the device software [10–12, 18–
21]. All participants baseline and follow up imaging was required to be of high quality, i.e. reli-
able visual fields with limited fixation losses and false-positive and false-negative results, and
strong OCT and HRT III quality scores that were clinically valid to be included in our analysis.
Statistical analysis involved performing a mixed-model analysis of covariance (ANCOVA) to
test for significant change from baseline to five-year follow up. Factors associated with OAG
functional progression were analyzed using Cox proportional hazards models in the PHREG
program within SAS statistical software (SAS Institute Inc, Cary, NC); in detail, additional
analyses explored the interaction of baseline OCT and HRT-III structural parameters with
presence or absence of an increase in IOP of at least 3 mmHg from baseline to 5 years.
Results
In this study, 112 patients with OAG were enrolled according to the prior listed inclusion and
exclusion criteria. Overall baseline characteristics of the population revealed a mean age
64.9 ± 11.0 years; female (n = 68), male (n = 44); African descent (n = 29), European descent
(n = 83); and non-insulin-dependent diabetes mellitus (n = 21), no diabetes mellitus (n = 91).
Table 1 shows the values for IOP, MD, AGIS score, OCT-measured average RNFL thick-
ness, cup/disc horizontal ratio, and cup/disc vertical ratio at baseline and at five years. Each
parameter had a statistically significant change when comparing measurements between the
baseline and five-year values except for the average RNFL (p = 0.174). IOP significantly
decreased at five years compared to baseline, while both the horizontal and vertical cup/disc
ratios significantly increased. Functional visual field loss occurred in the patients, as there was
a statistically significant decrease in the MD and a statistically significant increase in the AGIS
score.
Table 2 displays the changes in ONH and RNFL structural measurements from baseline to
five years obtained using OCT and HRT-III imaging.
Table 3 condenses Table 2 into a solitary table where it highlights the structural parameters
for each imaging modality that were shown to have a statistically significant change from the
Table 1. Overall change in structural and functional measurements from baseline to five years.
Baseline 5-yr Change
N Mean (95% CI) N Mean (95% CI) Mean (95% CI) P-value
IOP 111 16.68 (15.52, 17.84) 75 15.28 (14.01, 16.54) -1.41 (-2.36, -0.45) 0.004�
MD 111 -3.38 (-4.43, -2.34) 78 -4.88 (-6.18, -3.57) -1.49 (-2.35, -0.63) 0.001�
AGIS score 111 1.41 (0.86, 2.12) 77 2.14 (1.37, 3.16) 0.56 (0.28, 0.81) < .001�
RNFL thickness average 111 74.91 (70.11, 79.70) 71 72.82 (67.59, 78.05) -2.09 (-5.10, 0.92) 0.174
Cup/disc horizontal ratio 112 0.70 (0.65, 0.74) 73 0.76 (0.71, 0.80) 0.06 (0.03, 0.08) < .001�
Cup/disc vertical ratio 112 0.684 (0.639, 0.730) 73 0.716 (0.666, 0.767) 0.032 (0.005, 0.059) 0.018�
AGIS: advanced glaucoma index score; CI: confidence interval; IOP: intraocular pressure; MD: mean deviation; N: number of patients who underwent the specific
examination indicated in each row of the table at baseline and at 5 years; the number of patients who completed the study was not the same for different examinations,
thus the difference between the “N” at baseline and after 5 years in the different rows of the table; RNFL: retinal nerve fiber layer.
�Bold P-value denotes a statistically significant difference between baseline and five-year follow up for all patients (p<0.05).
https://doi.org/10.1371/journal.pone.0236819.t001
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baseline to five-year measurements. Notably, not all of the structural parameters measured on
OCT were measured on the HRT-III, and vice versa.
Functional disease progression was detected in 37 of the 112 patients (26 of European
descent and 11 of African descent; 33%). In our study we did not find a statistically significant
correlation between baseline central corneal thickness and functional progression after 5 years
(p value = 0.8747).
Table 4 illustrates baseline ONH and RNFL structural measurements assessed by OCT and
HRT-III and their relation to functional visual field loss over the five-year period.
Cox proportional hazards models show that baseline OCT measurements in patients with a
larger disc area (Hazard ratio, HR 1.53 for a disc area difference of 0.5; p = 0.008), a larger cup
area (HR 1.48 for 0.5 difference; p = 0.003), or a thinner RNFL temporal thickness (HR 1.63
for 0.5 difference; p = 0.003) were associated with a statistically significant shorter time to func-
tional disease progression.
Similarly, certain baseline HRT-III measurements in these patients were also associated
with a shorter time to functional disease progression. These baseline HRT-III measurements
Table 2. Overall change in OCT and HRT-III measurements from baseline to five years.
Baseline 5-yr Change
N Mean (95% CI) N Mean (95% CI) Mean (95% CI) P-value
OCT
Disc area 112 2.272 (2.141, 2.403) 73 2.618 (2.469, 2.766) 0.346 (0.249, 0.442) < .001�
Cup area 112 1.184 (1.016, 1.352) 73 1.513 (1.324, 1.703) 0.329 (0.234, 0.425) < .001�
Rim area 112 1.080 (0.950, 1.211) 73 1.104 (0.963, 1.246) 0.024 (-0.071, 0.119) 0.620
Cup/disc area ratio 112 0.514 (0.455, 0.574) 73 0.572 (0.509, 0.634) 0.058 (0.026, 0.090) < .001�
Cup/disc horizontal ratio 112 0.70 (0.65, 0.74) 73 0.76 (0.71, 0.80) 0.06 (0.03, 0.08) < .001�
Cup/disc vertical ratio 112 0.684 (0.639, 0.730) 73 0.716 (0.666, 0.767) 0.032 (0.005, 0.059) 0.018�
RNFL thickness superior 112 89.08 (82.24, 95.92) 71 82.85 (75.58, 90.13) -6.23 (-10.80, -1.66) 0.008�
RNFL thickness inferior 112 91.32 (83.09, 99.55) 71 87.41 (78.10, 96.73) -3.91 (-9.24, 1.42) 0.150
RNFL thickness nasal 112 63.15 (58.44, 67.86) 71 65.93 (60.15, 71.71) 2.78 (-1.58, 7.14) 0.211
RNFL thickness temporal 112 54.93 (50.02, 59.84) 71 54.44 (49.07, 59.81) -0.49 (-3.90, 2.92) 0.779
RNFL average 112 74.91 (70.11, 79.70) 71 72.82 (67.59, 78.05) -2.09 (-5.10, 0.92) 0.174
HRT-III
Cup Area 111 0.870 (0.735, 1.015) 77 0.908 (0.768, 1.059) 0.037 (-0.001, 0.075) 0.057
Rim Area 111 1.268 (1.159, 1.377) 77 1.227 (1.115, 1.339) -0.041 (-0.083, 0.002) 0.060
Cup Volume 111 0.296 (0.224, 0.368) 77 0.319 (0.246, 0.392) 0.023 (0.003, 0.042) 0.021�
Rim Volume 111 0.295 (0.246, 0.344) 77 0.292 (0.242, 0.341) -0.003 (-0.022, 0.015) 0.719
Cup/Disc Area Ratio 111 0.410 (0.359, 0.461) 77 0.429 (0.377, 0.482) 0.019 (0.000, 0.038) 0.046�
Linear Cup/Disc Ratio 111 0.619 (0.573, 0.665) 77 0.632 (0.584, 0.679) 0.013 (-0.003, 0.029) 0.102
Mean Cup Depth 111 0.300 (0.266, 0.334) 77 0.309 (0.275, 0.343) 0.009 (0.001, 0.018) 0.036�
Max Cup Depth 111 0.724 (0.659, 0.790) 77 0.730 (0.665, 0.795) 0.006 (-0.015, 0.027) 0.581
Cup Shape 111 -0.128 (-0.149, -0.108) 77 -0.115 (-0.137, -0.092) 0.014 (0.004, 0.024) 0.008�
Height Variation Contour 111 0.330 (0.297, 0.366) 77 0.353 (0.316, 0.396) 0.022 (0.004, 0.040) 0.020�
Mean RNFL Thickness 111 0.196 (0.172, 0.219) 77 0.185 (0.159, 0.210) -0.011 (-0.025, 0.003) 0.123
RNFL Cross-Sectional Area 111 1.025 (0.901, 1.148) 77 0.973 (0.839, 1.108) -0.051 (-0.125, 0.022) 0.169
CI: confidence interval; HRT-III: Heidelberg retinal tomography-III; N: number of patients who underwent the specific examination indicated in each row of the table
at baseline and at 5 years; the number of patients who completed the study was not the same for different examinations, thus the difference between the “N” at baseline
and after 5 years in the different rows of the table; OCT: optical coherence tomography; RNFL: retinal nerve fiber layer.
�Bold P-value denotes a statistically significant difference between baseline and five-year follow up for all patients (p<0.05).
https://doi.org/10.1371/journal.pone.0236819.t002
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include a larger cup area (HR 2.50 for a cup area difference of 0.5; p = 0.004), a greater cup/
disc area ratio (HR 1.79 for 0.2 difference; p = 0.004), a greater linear cup/disc ratio (HR 2.01
for 0.2 difference; p = 0.007), a greater cup shape value (HR 1.70 for 0.1 difference; p = 0.032),
a smaller rim area (HR 1.60 for 0.5 difference; p = 0.039), a smaller rim volume (HR 2.17 for
0.2 difference; p = 0.005), a smaller height variation contour (HR 1.19 for 0.2 difference;
p = 0.041), a smaller RNFL cross-sectional area (HR 2.02 for 0.5 difference; p<0.001), or a
thinner mean RNFL thickness (HR 2.32 for 0.1 difference; p = 0.002).
Table 5 is a condensed version of Table 4 showing only the parameters that were statistically
significant for each imaging modality. Notably, not all of the structural parameters measured
on OCT were measured on the HRT-III and vice versa.
Additional analyses explored the interaction of baseline OCT and HRT-III structural
parameters with presence (12) or absence (63) of an increase in IOP of at least 3 mmHg over
the five years on time to progression. Baseline OCT measurements for cup area (p = 0.048)
and cup/disc area ratio (p = 0.022) were more strongly associated with shorter time to func-
tional disease progression in patients with increased IOP than in patients who did not experi-
ence an increase in IOP. Many other OCT and HRT-III parameters displayed similar
differences between the two groups, but the differences did not reach statistical significance.
Discussion
In this study, we tracked ONH and RNFL structure over a five-year period using OCT and
HRT-III imaging in order to determine if baseline structural parameters may be associated
with a shorter time to functional progression in patients who already had a diagnosis of open-
angle glaucoma. As progressive OAG represents an increasing impact on quality of life
through an ageing population, advancing specificity in diagnostic outcomes will significantly
affect patient quality of life [22]. Our results strongly support previous investigations that have
identified baseline ONH and RNFL characteristics that are associated with shorter time to
functional glaucoma progression. Furthermore, our results identify additional structural char-
acteristics that are associated with a shorter time to functional glaucoma progression.
Table 3. Summary of statistically significant P-values for the change in structural parameters seen on OCT and
HRT-III when comparing the baseline to five-year measurements for the study population.
Structural parameter OCT HRT-III
Disc area < .001� (") Not measured
Cup area < .001� (") 0.057
Cud/disc area ratio < .001� (") 0.0046� (")
Cup/disc horizontal ratio < .001� (") 0.102
Cup/disc vertical ratio 0.018� (") 0.102
Mean cup depth Not measured 0.036� (")
Cup shape Not measured 0.008� (")
Superior RNFL thickness 0.008� (#) Not measured
Height variation contour Not measured 0.020� (")
Mean RNFL thickness 0.174 0.123
OCT: optical coherence tomography; RNFL, retinal nerve fiber layer.
�Bold P-value denotes a statistically significant difference between baseline and five-year follow up for all patients
(p<0.05). An arrow facing up (") means there was an increase in value when comparing baseline to five-year
parameter values, whereas an arrow facing down (#) means there was a decrease in value when comparing baseline to
five-year parameter.
https://doi.org/10.1371/journal.pone.0236819.t003
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Specifically, our findings showed that patients with a larger baseline disc area, a larger cup
area, a larger cup/disc area ratio, or a larger linear cup/disc ratio were associated with shorter
time to functional glaucoma progression. These findings are supported by previous reports
from the Ocular Hypertension Treatment Study that found that the ONH vertical and hori-
zontal cup-disc ratios were structural parameters strongly associated with the onset of OAG
[8]. In addition to cup/disc ratios, the evaluation of the RNFL thickness by OCT and HRT-III
can be useful in the clinical setting, as certain RNFL characteristics were associated with a
shorter time to functional disease progression over the course of five years. Similar to our find-
ings, Sehi et al. showed that progressive RNFL loss was associated with functional glaucoma
progression [13], while Lalezary et al. showed that thinner baseline RNFL, as measured by
OCT, was an independent predictor of functional glaucomatous changes [14]. Our data also
show that baseline optic disc cup shape, based on measures of the topography including cup
size, cup depth, neuroretinal rim slope, and RNFL curvature, appears to be a significant predic-
tor of glaucoma progression. In a study of 80 patients with exfoliation syndrome, Harju and
Vesti reported that among HRT parameters, only cup shape measurements showed statistically
significant change in MD [15]. Similarly, in a study of 68 eyes with OAG, Saarela and
Table 4. Baseline ONH and RNFL structural measurements by OCT and HRT-III and their relation to functional visual field loss over the five-year period.
Functional Progression after 5 years No Functional Progression after 5 years Hazard Ratio (95% CI) P-value
[N = 37] Mean (SE) [N = 75] Mean (SE)
OCT
Disc area 2.403 (0.092) 2.180 (0.046) 1.53 (1.12–2.09) for difference of 0.5 0.008�
Cup area 1.398 (0.110) 1.110 (0.059) 1.48 (1.14–1.92) for difference of 0.5 0.003�
Rim area 1.004 (0.072) 1.070 (0.054) 0.83 (0.58–1.19) for difference of 0.5 0.311
Cup/disc area ratio 0.566 (0.034) 0.512 (0.025) 1.28 (0.95–1.74) for difference of 0.2 0.108
Cup/disc horizontal ratio 0.75 (0.03) 0.70 (0.02) 1.45 (0.95–2.23) for difference of 0.2 0.084
Cup/disc vertical ratio 0.726 (0.026) 0.685 (0.019) 1.42 (0.92–2.19) for difference of 0.2 0.113
RNFL thickness superior 84.05 (4.05) 89.77 (2.92) 0.80 (0.57–1.11) for difference of 25 0.183
RNFL thickness inferior 84.97 (4.07) 92.92 (3.53) 0.78 (0.58–1.05) for difference of 25 0.108
RNFL thickness nasal 63.78 (3.77) 60.19 (2.11) 1.17 (0.78–1.75) for difference of 25 0.445
RNFL thickness temporal 53.24 (2.31) 61.43 (1.91) 0.61 (0.44–0.84) for difference of 15 0.003�
Mean RNFL thickness 71.52 (2.61) 76.07 (2.08) 0.78 (0.59–1.05) for difference of 15 0.097
HRT-III
Cup Area 1.094 (0.093) 0.830 (0.051) 2.50 (1.34–4.68) for difference of 0.5 0.004�
Rim Area 1.151 (0.059) 1.298 (0.049) 0.62 (0.40–0.98) for difference of 0.5 0.039�
Cup Volume 0.331 (0.050) 0.243 (0.026) 1.32 (0.97–1.79) for difference of 0.3 0.077
Rim Volume 0.222 (0.019) 0.314 (0.021) 0.46 (0.29–0.79) for difference of 0.2 0.005�
Cup/Disc Area Ratio 0.469 (0.029) 0.382 (0.020) 1.79 (1.20–2.65) for difference of 0.2 0.004�
Linear Cup/Disc Ratio 0.672 (0.023) 0.595 (0.019) 2.01 (1.21–3.34) for difference of 0.2 0.007�
Mean Cup Depth 0.293 (0.020) 0.284 (0.015) 1.11 (0.68–1.81) for difference of 0.2 0.678
Max Cup Depth 0.684 (0.034) 0.701 (0.030) 0.93 (0.63–1.36) for difference of 0.3 0.699
Cup Shape -0.112 (0.013) -0.134 (0.008) 1.70 (1.05–2.75) for difference of 0.1 0.032�
Height Variation Contour 0.317 (0.017) 0.376 (0.016) 0.84 (0.71–0.99) for difference of 0.2 0.041�
Mean RNFL Thickness 0.156 (0.011) 0.208 (0.009) 0.43 (0.27–0.69) for difference of 0.1 <0.001�
RNFL Cross-Sectional Area 0.825 (0.057) 1.074 (0.051) 0.50 (0.32–0.77) for difference of 0.5 0.002�
HRT-III: Heidelberg retinal tomography-III; N: number of patients; OCT: optical coherence tomography; ONH: optic nerve head; RNFL: retinal nerve fiber layer; SE:
Standard Error.
�Bold P-value denotes a statistically significant difference between patients who progressed and those who did not progress (p<0.05).
https://doi.org/10.1371/journal.pone.0236819.t004
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Airaksinen found that cup shape was the only optic nerve head parameter that showed a statis-
tically significant correlation with progression of an RNFL defect [16]. Interestingly, our data
shows an increase in disc area and rim area when measured by OCT. In the Baltimore study,
similar results regarding increase in disc area were found although they were unable to find
statistical significance [23]. Unlike previous studies such as the one performed by Hammel
et al., our OCT measurements found an increase in rim area, which is unusual [24]. Taken
together, these research findings may be useful for the development of prediction models
which could utilize baseline structural change in newly-diagnosed OAG patients to determine
whether patients are likely to progress, the rate at which they may progress, and if they require
earlier intervention (i.e., pharmacologic, procedural, and/or operative) at the time of diagnosis.
Such models would greatly simplify the decision-making process for clinicians who manage
patients with OAG.
We also explored as to whether patients who experienced an increase in IOP over the five
years displayed different associations between the baseline structural parameters and func-
tional disease progression. The patients were categorized as having increased IOP if the IOP
increased by at least 3 mmHg from baseline to 5 years. This was determined to be the smallest
value to use for defining an IOP increase given the variability in the IOP measurements. It is
worth noting, however, that only 12 of the 75 patients with 5-year changes in IOP had an
increase of 3 mmHg or more. These results indicate a possible difference in the risk for func-
tional disease progression associated with baseline structure with versus without subsequent
changes in IOP, but a larger study would be needed to further clarify this difference.
This study has several strengths, such as having a relatively large study population prospec-
tively evaluated over a long period of time, a single imaging data collector to limit reproduc-
ibility bias, and stringent exclusion criteria. However, we recognize that our study is not
without limitations. Our study lacks a control group of healthy, non-glaucoma patients; thus,
our ability is limited in drawing correlations between structural and functional changes that
Table 5. Summary of statistically significant HR and P-values from differences in baseline values for various
structural parameters acquired by OCT and HRT-III between patients who progressed at 5 years and those who
did not.
Structural parameter OCT HRT-III
Disc area HR 1.53; p = 0.008� (") Not measured
Cup area HR 1.48; p = 0.003� (") HR 2.50; p = 0.004� (")
Cup/disc area ratio 0.108 HR 1.79; p = 0.004� (")
Linear cup/disc ratio Not measured HR 2.01; p = 0.007� (")
Cup shape Not measured HR 1.70; p = 0.032� (")
Rim area 0.311 HR 1.60; p = 0.039� (#)
Rim volume Not measured HR 2.17; p = 0.005� (#)
Height variation contour Not measured HR 1.19; p = 0.041� (#)
Mean RNFL thickness 0.097 HR 2.32; p< 0.001� (#)
Temporal RNFL thickness HR 1.63; p = 0.003� (") Not measured
RNFL cross-sectional area Not measured HR 2.02; p = 0.002� (#)
HR: hazard ratio; HRT-III: Heidelberg retinal tomography-III; OCT: optical coherence tomography; RNFL: retinal
nerve fiber layer.
�Bold P-value denotes a statistically significant difference between baseline and five-year follow up for all patients
(p<0.05). An arrow facing up (") means a larger baseline value was associated with functional progression, whereas
an arrow facing down (#) means a lower baseline value was associated with functional progression at 5 years;
insignificant HRs were omitted.
https://doi.org/10.1371/journal.pone.0236819.t005
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may be seen in healthy controls. Since there were no criteria established for excluding patients
with advanced disease at baseline, there is a chance of introducing bias. Additionally, participa-
tion in this study did not affect glaucoma treatment; thus, patients were on different types and
amounts of ocular antihypertensives throughout the course of this study. Additionally, many
patients were also on systemic antihypertensives, which could have an effect on disease pro-
gression due to differences in ocular perfusion pressure status [25].
In conclusion, this study revealed specific prognostic baseline structural characteristics of
the ONH and RNFL that were associated with functional glaucoma progression. These data
may help in determining algorithms with higher specificity to predict glaucoma risk and risk
for progression in patients with glaucoma.
Supporting information
S1 Fig. Survival function for time to progression for baseline disc area and cup area mea-
sured with optical coherence tomography. Lines represent survival curves for lowest and
highest observed values for each measurement. Higher baseline disc area and cup area were
associated with shorter time to functional progression. HR-hazard ratio.
(PDF)
S2 Fig. Survival function for time to functional progression for baseline linear cup/disc
ratio, cup area, cup shape, rim area, rim volume, height variation contour, mean retinal
nerve fiber layer (RNFL) thickness, and RNFL cross-sectional area measured with Heidel-
berg retinal tomography-III. Lines represent survival curves for lowest and highest observed
values for each measurement. Higher baseline linear cup/disc ratio, cup area, and cup shape
and lower baseline rim area, rim volume, height variation contour, mean RNFL thickness, and
RNFL cross-sectional area were associated with shorter time to functional progression.
(PDF)
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